In-Vitro Application of Magnetic Hybrid Niosomes: Targeted siRNA-Delivery for Enhanced Breast Cancer Therapy

Even though the administration of chemotherapeutic agents such as erlotinib is clinically established for the treatment of breast cancer, its efficiency and the therapy outcome can be greatly improved using RNA interference (RNAi) mechanisms for a combinational therapy. However, the cellular uptake...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Viktor, Altin, Selin, Ag Seleci, Didem, Zarinwall, Ajmal, Temel, Bilal, Vogt, Peter M., Strauß, Sarah, Stahl, Frank, Scheper, Thomas, Bucan, Vesna, Garnweitner, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002368/
https://www.ncbi.nlm.nih.gov/pubmed/33809700
http://dx.doi.org/10.3390/pharmaceutics13030394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002368/
https://www.ncbi.nlm.nih.gov/pubmed/33809700
http://dx.doi.org/10.3390/pharmaceutics13030394

Ejemplares similares